George P Kim, MD

Dr. George Kim is a board certified medical oncologist specializing in gastrointestinal oncology. He recently joined the University of Florida Health Cancer Center in Gainesville, Florida. After receiving a medical degree from the University of Vermont, College of Medicine, he completed internship and residency at the Johns Hopkins Hospital. Dr. Kim then completed medical oncology fellowship at the National Cancer Institute where he conducted laboratory research involving microsatellite instability and analyzed archived specimens from several National Surgical Breast and Bowel Project colorectal cancer phase III trials. This published work helps define the predictive and prognostic roles of high-degree microsatellite instability in the adjuvant setting. He subsequently joined Mayo Clinic Florida and served as the Director of the Gastrointestinal Cancer Section, the Phase I Program and the Research Affiliates Network. He also served as the Director of GI Oncology at the George Washington University Cancer Center. Dr. Kim served as the principal investigator of several GI cancer trials conducted through the North Central Cancer Treatment Group, Phase 2 Consortium and Mayo Clinic Cancer Center involving colorectal, pancreatic and hepatocellular cancers. These trials focused on combining contemporary chemotherapy with novel biologic agents and had significant focus on predictive markers. Dr. Kim was also a principal investigator in Mayo Clinic Pancreas Cancer SPORE and funded to study predictive markers of gemcitabine activity. He served on U.S. Intergroup committees, both Pancreas and Colon Cancer Task Forces. He published numerous reports on the treatment of these cancers and on the discovery of predictive markers. Dr. Kim authored numerous peer-reviewed manuscripts and multiple book chapters. He served on patient advocacy boards for stomach and pancreatic cancer.